Author Bouter, Yvonne

1 to 20 of 20 Items
  • 2013 Journal Article
    ​ ​P2–381: Tg4–42: A new mouse model of Alzheimer's disease—N‐truncated beta‐amyloid 4–42 affects memory decline and synaptic plasticity​
    Dietrich, K.; Bouter, Y.; Wittnam, J.; Pillot, T.; Papot‐Couturier, S.; Lefebvre, T. & Sprenger, F. et al.​ (2013) 
    Alzheimer's & Dementia9(4S_Part_12).​ DOI: https://doi.org/10.1016/j.jalz.2013.05.1030 
    Details  DOI 
  • 2013 Journal Article
    ​ ​P2–382: Tg4–42: A new mouse model of Alzheimer's disease—N‐truncated amyloid β (Aβ) 4–42 induces severe neuron loss and behavioral deficits​
    Bouter, Y.; Dietrich, K.; Wittnam, J.; Pillot, T.; Papot‐Couturier, S.; Lefebvre, T. & Sprenger, F. et al.​ (2013) 
    Alzheimer's & Dementia9(4S_Part_12).​ DOI: https://doi.org/10.1016/j.jalz.2013.05.1031 
    Details  DOI 
  • 2013 Journal Article | 
    ​ ​N-truncated amyloid beta (A beta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits​
    Bouter, Y.; Dietrich, K.; Wittnam, J. L.; Rezaei-Ghaleh, N.; Pillot, T.; Papot-Couturier, S. & Lefebvre, T. et al.​ (2013) 
    Acta Neuropathologica126(2) pp. 189​-205​.​ DOI: https://doi.org/10.1007/s00401-013-1129-2 
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article | 
    ​ ​Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing​
    Bouter, Y.; Kacprowski, T.; Weissmann, R.; Dietrich, K.; Borgers, H.; Brauss, A. & Sperling, C. et al.​ (2014) 
    Frontiers in Aging Neuroscience6.​ DOI: https://doi.org/10.3389/fnagi.2014.00075 
    Details  DOI  WoS 
  • 2014 Journal Article | 
    ​ ​Abundance of Aß5-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer´s disease​
    Guzmán, E. A.; Bouter, Y.; Richard, B. C.; Lannfelt, L.; Ingelsson, M.; Paetau, A. & Verkkoniemi-Ahola, A. et al.​ (2014) 
    Molecular Neurodegeneration9(1) art. 13​.​ DOI: https://doi.org/10.1186/1750-1326-9-13 
    Details  DOI  PMID  PMC 
  • 2015 Journal Article
    ​ ​Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta(3-42)​
    Meissner, J. N.; Bouter, Y. & Bayer, T. A.​ (2015) 
    Journal of Alzheimer s Disease45(2) pp. 471​-482​.​ DOI: https://doi.org/10.3233/JAD-142868 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article | 
    ​ ​Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X​
    Antonios, G.; Borgers, H.; Richard, B. C. ; Brauss, A.; Meissner, J.; Weggen, S. & Pena, V. et al.​ (2015) 
    Scientific Reports5 art. 17338​.​ DOI: https://doi.org/10.1038/srep17338 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article | 
    ​ ​Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier​
    Storck, S. E.; Meister, S.; Nahrath, J.; Meissner, J. N.; Schubert, N.; Di Spiezio, A. & Baches, S. et al.​ (2016) 
    Journal of Clinical Investigation126(1) pp. 123​-136​.​ DOI: https://doi.org/10.1172/JCI81108 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease​
    Weissmann, R.; Huettenrauch, M.; Kacprowski, T.; Bouter, Y.; Pradier, L.; Bayer, T. A. & Kuss, A. W. et al.​ (2016) 
    Journal of Alzheimer s Disease50(2) pp. 397​-409​.​ DOI: https://doi.org/10.3233/JAD-150745 
    Details  DOI  PMID  PMC  WoS 
  • 2018 Journal Article | 
    ​ ​Synergistic Effect on Neurodegeneration by N-Truncated Aβ4-42 and Pyroglutamate Aβ3-42 in a Mouse Model of Alzheimer's Disease.​
    Lopez-Noguerola, J. S.; Giessen, N. M. E.; Ueberück, M.; Meißner, J. N.; Pelgrim, C. E.; Adams, J. & Wirths, O.  et al.​ (2018) 
    Frontiers in aging neuroscience10 art. 64​.​ DOI: https://doi.org/10.3389/fnagi.2018.00064 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article | 
    ​ ​Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease​
    Wagner, J. M.; Sichler, M. E.; Schleicher, E. M.; Franke, T. N.; Irwin, C.; Löw, M. J. & Beindorff, N. et al.​ (2019) 
    Frontiers in Behavioral Neuroscience13 art. 107​.​ DOI: https://doi.org/10.3389/fnbeh.2019.00107 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease​
    Bouter, C.; Henniges, P.; Franke, T. N.; Irwin, C.; Sahlmann, C. O.; Sichler, M. E. & Beindorff, N. et al.​ (2019) 
    Frontiers in Aging Neuroscience10 art. 125​.​ DOI: https://doi.org/10.3389/fnagi.2018.00425 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Reduced Acoustic Startle Response and Prepulse Inhibition in the Tg4-42 Model of Alzheimer’s Disease​
    Sichler, M. E.; Löw, M. J.; Schleicher, E. M.; Bayer, T. A. & Bouter, Y.​ (2019) 
    Journal of Alzheimer's Disease Reports3(1) pp. 269​-278​.​ DOI: https://doi.org/10.3233/ADR-190132 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice​
    Schleicher, E. M.; Ott, F. W.; Müller, M.; Silcher, B.; Sichler, M. E.; Löw, M. J. & Wagner, J. M. et al.​ (2019) 
    Frontiers in Behavioral Neuroscience13 art. 94​.​ DOI: https://doi.org/10.3389/fnbeh.2019.00094 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease​
    Bakrania, P.; Hall, G.; Bouter, Y.; Bouter, C.; Beindorff, N.; Cowan, R. & Davies, S. et al.​ (2021) 
    Molecular Psychiatry,.​ DOI: https://doi.org/10.1038/s41380-021-01385-7 
    Details  DOI 
  • 2021 Journal Article | Research Paper | 
    ​ ​Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations​
    Bouter, C.; Irwin, C.; Franke, T. N.; Beindorff, N. & Bouter, Y.​ (2021) 
    Frontiers in Medicine8.​ DOI: https://doi.org/10.3389/fmed.2021.745064 
    Details  DOI 
  • 2022 Journal Article
    ​ ​Small RNA Sequencing in the Tg4–42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer’s Disease​
    Lio, C. T.; Kacprowski, T.; Klaedtke, M.; Jensen, L. R.; Bouter, Y.; Bayer, T. A. & Kuss, A. W.​ (2022) 
    Journal of Alzheimer's Disease, pp. 1​-11​.​ DOI: https://doi.org/10.3233/JAD-220110 
    Details  DOI 
  • 2022 Journal Article | 
    ​ ​Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer’s disease and Down syndrome​
    Bouter, Y.; Liekefeld, H.; Pichlo, S.; Westhoff, A. C.; Fenn, L.; Bakrania, P. & Bayer, T. A.​ (2022) 
    Acta Neuropathologica143(5) pp. 601​-603​.​ DOI: https://doi.org/10.1007/s00401-022-02418-3 
    Details  DOI 
  • 2023 Journal Article | 
    ​ ​Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice​
    Bouter, C.; Ott, F. W.; Günther, D.; Weig, L.; Schmitz-Peiffer, F.; Rozyyeva, M. & Beindorff, N. et al.​ (2023) 
    Journal of Neural Transmission,.​ DOI: https://doi.org/10.1007/s00702-023-02607-8 
    Details  DOI 
  • 2024 Journal Article | Erratum
    ​ ​Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models​
    Bouter, Y.; Noguerola, J. S. L.; Tucholla, P.; Crespi, G. A. N.; Parker, M. W.; Wiltfang, J. & Miles, L. A. et al.​ (2024) 
    Acta Neuropathologica147(1).​ DOI: https://doi.org/10.1007/s00401-024-02718-w 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page